Suppr超能文献

从肿瘤细胞和酵母展示的肿瘤抗原选择的噬菌体文库中内化癌症抗体。

Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens.

机构信息

Department of Anesthesia and Pharmaceutical Chemistry, University of California, San Francisco, Room 3C-38,San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.

出版信息

J Mol Biol. 2010 Nov 19;404(1):88-99. doi: 10.1016/j.jmb.2010.09.006. Epub 2010 Sep 17.

Abstract

A number of approaches have been utilized to generate antibodies to cancer cell surface receptors that can be used as potential therapeutics. A number of these therapeutic approaches, including antibody-drug conjugates, immunotoxins, and targeted nucleic acid delivery, require antibodies that not only bind receptor but also undergo internalization into the cell upon binding. We previously reported on the ability to generate cancer cell binding and internalizing antibodies directly from human phage antibody libraries selected for internalization into cancer cell lines. While a number of useful antibodies have been generated using this approach, limitations include the inability to direct the selections to specific antigens and to identify the antigen bound by the antibodies. Here we show that these limitations can be overcome by using yeast-displayed antigens known to be associated with a cell type to select the phage antibody output after several rounds of selection on a mammalian cell line. We used this approach to generate several human phage antibodies to yeast-displayed EphA2 and CD44. The antibodies bound both yeast-displayed and mammalian cell surface antigens, and were endocytosed upon binding to mammalian cells. This approach is generalizable to many mammalian cell surface proteins, results in the generation of functional internalizing antibodies, and does not require antigen expression and purification for antibody generation.

摘要

已经有许多方法被用于生成针对癌细胞表面受体的抗体,这些抗体可以作为潜在的治疗药物。其中一些治疗方法,包括抗体药物偶联物、免疫毒素和靶向核酸递药,都需要既能够结合受体又能在结合后被内化到细胞内的抗体。我们之前曾报道过,直接从针对内化到癌细胞系的人噬菌体抗体文库中筛选出能够与癌细胞结合并内化的抗体的能力。虽然已经使用这种方法生成了许多有用的抗体,但存在的局限性包括无法将选择定向到特定的抗原,以及无法确定抗体结合的抗原。在这里,我们通过使用已知与细胞类型相关的酵母展示抗原,在对哺乳动物细胞系进行几轮选择后,筛选噬菌体抗体的输出,从而克服了这些局限性。我们使用这种方法生成了几种针对酵母展示 EphA2 和 CD44 的人源噬菌体抗体。这些抗体既结合酵母展示的抗原,也结合哺乳动物细胞表面抗原,并在与哺乳动物细胞结合后被内吞。这种方法适用于许多哺乳动物细胞表面蛋白,能够产生功能性的内化抗体,并且在生成抗体时不需要抗原表达和纯化。

相似文献

1
Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens.
J Mol Biol. 2010 Nov 19;404(1):88-99. doi: 10.1016/j.jmb.2010.09.006. Epub 2010 Sep 17.
3
Discovery of internalizing antibodies to tumor antigens from phage libraries.
Methods Enzymol. 2012;502:43-66. doi: 10.1016/B978-0-12-416039-2.00003-3.
4
Selection of tumor-specific internalizing human antibodies from phage libraries.
J Mol Biol. 2000 Sep 1;301(5):1149-61. doi: 10.1006/jmbi.2000.4026.
5
Identification of target and function specific antibodies for effective drug delivery.
Methods Mol Biol. 2009;525:145-60, xv. doi: 10.1007/978-1-59745-554-1_7.
7
Optimized selection of anti-tumor recombinant antibodies from phage libraries on intact cells.
Mol Immunol. 2014 Feb;57(2):317-22. doi: 10.1016/j.molimm.2013.10.009. Epub 2013 Nov 13.
10
Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.
Mol Immunol. 2007 Jul;44(15):3777-88. doi: 10.1016/j.molimm.2007.03.023. Epub 2007 May 10.

引用本文的文献

1
Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment-Drug Conjugates.
Biomolecules. 2020 Jun 25;10(6):955. doi: 10.3390/biom10060955.
3
Discovery of internalizing antibodies to basal breast cancer cells.
Protein Eng Des Sel. 2018 Jan 1;31(1):17-28. doi: 10.1093/protein/gzx063.
4
The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).
Pulm Circ. 2018 Jan-Mar;8(1):2045893217752329. doi: 10.1177/2045893217752329. Epub 2017 Dec 20.
5
Current progress in innovative engineered antibodies.
Protein Cell. 2018 Jan;9(1):86-120. doi: 10.1007/s13238-017-0457-8. Epub 2017 Aug 18.
6
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.
MAbs. 2017 Jan;9(1):58-67. doi: 10.1080/19420862.2016.1259047. Epub 2016 Nov 17.
7
Ligand-targeted theranostic nanomedicines against cancer.
J Control Release. 2016 Oct 28;240:267-286. doi: 10.1016/j.jconrel.2016.01.002. Epub 2016 Jan 6.
8
Targeted endothelial nanomedicine for common acute pathological conditions.
J Control Release. 2015 Dec 10;219:576-595. doi: 10.1016/j.jconrel.2015.09.055. Epub 2015 Oct 3.
9
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
Leukemia. 2016 Mar;30(3):692-700. doi: 10.1038/leu.2015.231. Epub 2015 Aug 19.
10
High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.
PLoS One. 2014 Oct 29;9(10):e111339. doi: 10.1371/journal.pone.0111339. eCollection 2014.

本文引用的文献

2
Libraries against libraries for combinatorial selection of replicating antigen-antibody pairs.
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1380-5. doi: 10.1073/pnas.0812291106. Epub 2009 Jan 12.
3
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Cancer Res. 2008 Nov 15;68(22):9280-90. doi: 10.1158/0008-5472.CAN-08-1776.
4
Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies.
Mol Cancer Ther. 2008 Mar;7(3):569-78. doi: 10.1158/1535-7163.MCT-07-2132. Epub 2008 Mar 4.
5
Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.
Mol Cancer Ther. 2007 Oct;6(10):2737-46. doi: 10.1158/1535-7163.MCT-07-0140.
7
Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer.
J Mol Med (Berl). 2007 Oct;85(10):1113-23. doi: 10.1007/s00109-007-0208-z. Epub 2007 Jun 7.
8
Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.
Mol Immunol. 2007 Jul;44(15):3777-88. doi: 10.1016/j.molimm.2007.03.023. Epub 2007 May 10.
9
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
J Biol Chem. 2007 Jun 1;282(22):16667-80. doi: 10.1074/jbc.M702078200. Epub 2007 Mar 28.
10
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell. 2006 Dec;10(6):515-27. doi: 10.1016/j.ccr.2006.10.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验